Research

New research shows bigger animals get more cancer, defying decades-old belief – Go Health Pro

by
New research shows bigger animals get more cancer, defying decades-old belief – Go Health Pro

The answer lies in how quickly body size evolves. We found that birds and mammals that reached large sizes more rapidly have reduced cancer prevalence. For example, the common dolphin, Delphinus delphis evolved to reach its large body size—along with most other whales and dolphins (referred to as cetaceans) about three times faster than other … Read more

Zacks Small Cap Research – CVKD: Collaborating with Abbott for Pivotal Phase 3 Trial… – Go Health Pro

by

By David Bautz, PhD NASDAQ:CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Collaboration Agreement with Abbott for Phase 3 TECH-LVAD Trial On March 4, 2025, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced a collaboration agreement with Abbott for the Phase 3 TECarfarin Anticoagulation and Hemocompatibility with Left Ventricular Assist Devices (TECH-LVAD) trial. In August 2024, Cadrenal … Read more

Zacks Small Cap Research – QNRX: More Positive Data Supporting Efficacy of QRX003 for NS; Campaign to Raise Awareness of the Disease – Go Health Pro

by
Zacks Small Cap Research – QNRX: More Positive Data Supporting Efficacy of QRX003 for NS; Campaign to Raise Awareness of the Disease – Go Health Pro

By M. Marin NASDAQ:QNRX READ THE FULL QNRX RESEARCH REPORT Positive interim clinical data Quoin Pharmaceuticals (NASDAQ:QNRX) is a clinical stage, specialty pharmaceutical company that focuses on developing treatments for rare and orphan diseases, initially in the dermatology space. The company is advancing clinical studies to evaluate lead asset QRX003 for the treatment of Netherton … Read more

Zacks Small Cap Research – EDSA: Raises $15 Million to Advance EB06… – Go Health Pro

by
Zacks Small Cap Research – EDSA: Raises Million to Advance EB06… – Go Health Pro

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Advancing EB06 for Treating Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease that causes areas of the skin to lose color, … Read more

Netherlands Institute of Human Rights Summer School; University of Singapore Vacancies; CfP Extension Ocean Governance; Early Career Research Exchange Series; ESIL Calls for Papers – EJIL: Talk! – Go Health Pro

by
Netherlands Institute of Human Rights Summer School; University of Singapore Vacancies; CfP Extension Ocean Governance; Early Career Research Exchange Series; ESIL Calls for Papers – EJIL: Talk! – Go Health Pro

1. Netherlands Institute of Human Rights International Human Rights Summer School. The Netherlands Institute of Human Rights (SIM) will be holding its annual summer school ‘International Human Rights Law: An Introduction’ again from 7 – 11 July 2025. Find more information about the summer school here.

2. University of Singapore Post-Doctoral Vacancies. The Centre for International Law at the National University of Singapore (NUS) is accepting applications for four Post-Doctoral positions.  The initial appointment is for one year with the possibility of extension to a second year based on the work accomplished during the first year. Applications are open to prospective fellows with research projects in all areas of International Law as well as other areas of public law with direct links to international law. More information about the positions is available here.

Read more

x